Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04532411 · ClinicalTrials.gov registry record
COVID-19 Testing Sample Acquisition Throughput and Efficiency
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 28,948
- Enrollment target
NCT04532411: Completed study, sponsored by Massachusetts General Hospital.
NCT04532411 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 28,948 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04532411 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 28,948 participants
- Enrollment target
Study Summary
This QI project seeks to evaluate the relative test sample acquisition throughput, personal protective equipment utilization, and relative operational costs of provider-administered COVID-19 (SARS-CoV-2) nasal samples with and with the use of HEPA-filtered, positive pressure isolation booths.
Interventions
- OTHER Personal Protective Testing Booth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28,948 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2020-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04532411
The ClinicalTrials.gov registry entry for NCT04532411 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28,948 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Personal Protective Testing Booth is the first listed.
NCT04532411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04532411 about?
NCT04532411 is a clinical study titled "COVID-19 Testing Sample Acquisition Throughput and Efficiency". This QI project seeks to evaluate the relative test sample acquisition throughput, personal protective equipment utilization, and relative operational costs of provider-administered COVID-19 (SARS-CoV-2) nasal samples with and with the use of HEPA-filtered, positive pressure isolation booths.
What is the current status of trial NCT04532411?
This trial is currently completed. The enrollment target is 28,948 participants. The study started on 2020-03-01. Estimated completion is 2020-09-30.
What interventions are being tested in trial NCT04532411?
The interventions under investigation include: Personal Protective Testing Booth (OTHER).
Who is sponsoring clinical trial NCT04532411?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.